Related Experiment Videos

Stimulant medications decrease energy expenditure and physical activity in children with

N F Butte1, M S Treuth, R G Voigt

  • 1US Department of Agriculture/Agricultural Research Service Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas 77030, USA.

Insights

Stimulant medications for attention-deficit/hyperactivity disorder (AD/HD) in children reduce physical activity and daily energy expenditure. This effect is primarily driven by decreased activity levels, not changes in metabolic rate.

Area of Science:

  • Pediatric Endocrinology
  • Neuroscience
  • Metabolic Research

Background:

  • Attention-deficit/hyperactivity disorder (AD/HD) is a common neurodevelopmental disorder in children.
  • Stimulant medications are a primary treatment for AD/HD, but their impact on energy metabolism requires further elucidation.
  • Understanding the effects of these medications on physical activity and energy expenditure is crucial for comprehensive patient care.

Purpose of the Study:

  • To investigate the impact of stimulant medications on energy expenditure, fuel utilization, and physical activity in children diagnosed with AD/HD.
  • To quantify changes in metabolic parameters during medication and withdrawal phases.

Main Methods:

  • A study involving 31 children (ages 6-12) with AD/HD.
  • Measurement of energy expenditure via room respiration calorimetry and physical activity using microwave motion detectors.
  • Comparison of data collected while children were on prescribed stimulant medication versus after a medication-free period of at least 24 hours.

Main Results:

  • Total and awake energy expenditure were 4-8% lower when children were on stimulant medication.
  • Physical activity levels were significantly reduced (16-22%) while on medication, accounting for the lower energy expenditure.
  • No significant effects of stimulant medication were observed on sleeping metabolic rate, basal metabolic rate, or fuel utilization.

Conclusions:

  • Stimulant medications demonstrably decrease physical activity in children with AD/HD.
  • The reduction in activity component significantly lowers total daily energy expenditure.
  • These findings highlight the importance of considering physical activity changes in the management of AD/HD with stimulant therapy.
Abstract

Related Concept Videos